Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-25-002081

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 17, 2025 12.01M sh
Shares Diluted Q3 2025 · Sep 30, 2025 10.24M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.21M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.65M sh
Capex Q3 2025 · Sep 30, 2025 $18K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$360.2K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$148.98K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.47M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1.23M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$1.57M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.46M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$1.81M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$1.87M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$1.8M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$1.65M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.59M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.59M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.73M
Current Assets Q3 2025 · Sep 30, 2025 $108.86K
Current Assets Q3 2025 · Dec 31, 2024 $261.89K
Total Assets Q3 2025 · Sep 30, 2025 $124.36K
Total Assets Q3 2025 · Dec 31, 2024 $261.89K
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.08
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.07
Sga Expense Q3 2025 · Sep 30, 2025 $250.97K
Sga Expense Q3 2025 · Sep 30, 2025 $592.25K
Sga Expense Q3 2025 · Sep 30, 2024 $40.4K
Sga Expense Q3 2025 · Sep 30, 2024 $76.69K
Net Income Q3 2025 · Sep 30, 2025 −$379.5K
Net Income Q3 2025 · Sep 30, 2025 −$734.55K
Net Income Q3 2025 · Jun 30, 2025 −$157.91K
Net Income Q3 2025 · Mar 31, 2025 −$197.14K
Net Income Q3 2025 · Sep 30, 2024 −$37.65K
Net Income Q3 2025 · Sep 30, 2024 −$527.37K
Net Income Q3 2025 · Jun 30, 2024 −$183.02K
Net Income Q3 2025 · Mar 31, 2024 −$306.71K
Operating Income Q3 2025 · Sep 30, 2025 −$265.69K
Operating Income Q3 2025 · Sep 30, 2025 −$794.06K
Operating Income Q3 2025 · Sep 30, 2024 −$121.94K
Operating Income Q3 2025 · Sep 30, 2024 −$264.75K
Gross Profit Q3 2025 · Sep 30, 2025 $3.85K
Gross Profit Q3 2025 · Sep 30, 2025 $4.91K
Gross Profit Q3 2025 · Sep 30, 2024 $0
Gross Profit Q3 2025 · Sep 30, 2024 $4.03K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $781
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.94K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $8.64K
Revenue Q3 2025 · Sep 30, 2025 $4.63K
Revenue Q3 2025 · Sep 30, 2025 $7.85K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $12.67K